Join the Merilog group to help and get support from people like you.
Merilog News
Advanced Tech Making Type 1 Diabetes More Manageable
THURSDAY, Aug. 14, 2025 — Advanced technology has boosted the ability of children and adults to manage their type 1 diabetes, a new study says. The number of kids under 18 who’ve achieved optimal con...
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
THURSDAY, July 31, 2025 – Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer's &...
Barbie's Latest Look? It Includes an Insulin Pump and Glucose Monitor
WEDNESDAY, July 9, 2025 — Barbie’s latest look includes a polka-dot crop top, chunky heels — and an insulin pump. Mattel has released its first-ever Barbie with type 1 diabetes, complete with a gluco...
Stem Cell Treatment May Free Some With Type 1 Diabetes From Insulin
TUESDAY, June 24, 2025 — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, c...
Monthly News Roundup - February 2025
FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy Izervay (avacincaptad pegol) from Astellas is now FDA-approved without a limitation on duration of dosing, allowing...
FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog
February 14, 2025 – Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to NovoLog (insulin aspart) for the improvement of glycemic control in adults...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
Further information
Related condition support groups
Diabetes, Type 2, Diabetes, Type 1